MAVIRET

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom

Active ingredients

The drug MAVIRET contains a combination of these active pharmaceutical ingredients (APIs):

1 Glecaprevir UNII K6BUU8J72P - GLECAPREVIR

Read about Glecaprevir

2 Pibrentasvir UNII 2WU922TK3L - PIBRENTASVIR

Pibrentasvir is a pan-genotypic inhibitor of HCV nonstructural protein 5A (NS5A), which is essential for viral RNA replication and virion assembly. Read about Pibrentasvir

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MAVIRET Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AP57		J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AP Antivirals for treatment of HCV infections
Discover more medicines within J05AP57

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11332K, 11333L, 11337Q, 11344C, 11345D, 11346E, 11353M, 11354N, 11355P
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 543718050003302
Country: CA	Health Products and Food Branch	Identifier(s): 02467550
Country: EE	Ravimiamet	Identifier(s): 1751037, 1852860, 1860016
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1171213001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 071635, 436586
Country: FR	Base de données publique des médicaments	Identifier(s): 63052124
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 346924
Country: HK	Department of Health Drug Office	Identifier(s): 65653
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8348
Country: IT	Agenzia del Farmaco	Identifier(s): 045445018, 045445032
Country: JP	医薬品医療機器総合機構	Identifier(s): 6250113D1020, 6250113F1021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1083656, 1093263
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 18901
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100392356, 100458876
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65905001
Country: SG	Health Sciences Authority	Identifier(s): 15603P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680656080506